QINLOCK (Tudorrose Consulting Pty Ltd)
123 working days (255)
QINLOCK (tablet) is a kinase inhibitor indicated for the treatment of adult patients with advanced gastrointestinal stromal tumours (GIST) who have received prior treatment with 3 or more kinase inhibitors, including imatinib.
Involves faster TGA evaluation of vital and life-saving medicines for which a complete data dossier is available
Sponsors receive a fee waiver to help bring medicines for a small population to market.